Revista Mexicana de Trastornos Alimentarios/Mexican Journal of Eating Disorders, Год журнала: 2022, Номер 12(1), С. 88 - 104
Опубликована: Июль 1, 2022
Revista Mexicana de Trastornos Alimentarios/Mexican Journal of Eating Disorders, Год журнала: 2022, Номер 12(1), С. 88 - 104
Опубликована: Июль 1, 2022
Acta Neurochirurgica, Год журнала: 2024, Номер 166(1)
Опубликована: Сен. 12, 2024
Язык: Английский
Процитировано
0Опубликована: Окт. 5, 2023
The main aim of this thesis is to obtain more insight in the risk factors and evaluate new treatments for hypothalamic-pituitary (HP) dysfunction children with a suprasellar brain tumor. Improving knowledge on presence consequences HP (suprasellar) tumor hopefully improves their outcome quality life may reduce health care costs long run. In part I (HP childhood craniopharyngioma), we focus identifying treatment cCP relation outcome. II (The clinical domains dysfunction), assessment dysfunction, diagnostics options signs symptoms within each separate domain (psychosocial disorders, hyperphagia, sleep disturbances, decreased energy expenditure, hyperinsulinemia/insulin resistance, pituitary dysfunction). last part, III other survivors), describe survivors tumors, excluding craniopharyngioma. Part Ι. craniopharyngioma chapter 2, discuss key aspects presentation cCP, including factors, current available therapeutic agents hypothalamic dysfunction. Chapter 3 presents nationwide retrospective review diagnosed period 2004 - 2021, evaluating effect shifting strategy ΙΙ. Signs assessed per 4, propose diagnostic criteria score syndrome. Moreover, evaluated score, two cohorts cohort low-grade glioma. 5, possibility deep stimulation (DBS) as option neurobehavioral patients obesity. 6 reports multicenter study dextroamphetamine 7, provide an overview etiology disturbances tumors. addition, flowchart help clinicians diagnose problems after (supra)sellar 8 tumors whom resting consumption was measured. We utility such measurements. 9 describes case series acquired obesity who were treated GLP-1 receptor agonist, improving BMI. 10 focuses safety GH replacement cCP. This includes systematic study. 11 prevalence associations growth elevated IGF-1 concentrations LGG children. III. 12 significant weight gain, overweight obesity, CBTS,
Язык: Английский
Процитировано
0Опубликована: Март 16, 2022
Ubiquitous technology, big data, more efficient electronic health records, and predictive analytics are now at the core of smart healthcare systems supported by artificial intelligence. In present narrative review, we focus on sensing technologies for Anorexia Nervosa (AN). We employed a framework inspired Interpersonal Neurobiology Theory (IPNB), which posits that human experience is characterized flow energy information both within us (within our whole body), between (in connections have with others nature). line this framework, focused sensors designed to evaluate bodily processes (body sensors: implantable sensors, epidermal wearable portable sensors), social interaction (sociometric physical environment (indoor outdoor ambient sensors). There myriad man-made as well nature-based such plants can be used design deploy intelligent monitoring healthcare. conclusion, smarter AN help relief burden professionals. However, there technical, ethical, environmental sustainability issues must considered prior implement these systems. A joint collaboration professionals other members society involved in individuals development The evolution cyberphysical should also collaborations.
Язык: Английский
Процитировано
0Revista Mexicana de Trastornos Alimentarios/Mexican Journal of Eating Disorders, Год журнала: 2022, Номер 12(1), С. 88 - 104
Опубликована: Июль 1, 2022
Процитировано
0